Exostatics Pharmaceuticals S.L. is a biotech company, spin-off from the University of Bordeaux (France). The company has developed a patented technology based on synthetic chemosensors for the efficient isolation of exosomes and other circulating microvesicles from biological fluids (urine, plasma, etc.) for use in the diagnosis and prognosis of diseases.
The patented compound has been validated in a proof of concept with urine and plasma samples for the detection of nephropathies, obtaining promising results in the uptake of these extracellular vesicles.
By not targeting a specific biomarker and with a simpler laboratory process which preserves the integrity of exosomes, we provide a broader set of applications both for diagnostic and therapeutic purposes, across multiple health conditions.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
What industry is Exostatics Pharmaceuticals in?
Exostatics Pharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Exostatics Pharmaceuticals based?
Exostatics Pharmaceuticals is headquartered in Barcelona, Spain.
Find investors for your startup like Exostatics Pharmaceuticals
Gritt sends AI-personalised outreach to each investor — from your Gmail
